Bridion Injection, Solution
Product Images NDC 84549-423

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bridion (NDC 84549-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Propharma Distribution, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (84549 423 12 Label)

BRIDION (sugammadex) Injection 100 mg/mL single dose vial, 2 mL. The label indicates the product is for intravenous use only, with storage instructions at 20 to 25 degrees Celsius and protection from light. It is packaged by ProPharma Distribution LLC, Westminster, CO, and includes manufacturer information from Merck Sharp & Dohme LLC. Barcode, NDC, lot, and expiration placeholders are present.*

FDA Label Image

Chemical Structure (Bridion 01)

Chemical structure diagram of sugammadex, the active ingredient in BRIDION injection, solution. The structure shows a cyclic molecule with multiple sugar-like rings and sodium carboxylate groups attached.*

FDA Label Image

Chemical Structure (Bridion 02)

Chemical structure diagram of sugammadex, the active ingredient in BRIDION injection, solution. The diagram depicts molecular bonds and functional groups typical of sugammadex's cyclic oligosaccharide structure with multiple sodium carboxylate groups.*

FDA Label Image

Figure 1 (Bridion 03)

A cumulative recovery rate plot comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time in minutes. The x-axis represents time to recovery (0 to 120 minutes), and the y-axis shows cumulative recovery rate (0 to 1.0). Sugammadex has a steeper recovery curve with a median recovery time of 1.4 minutes, while neostigmine shows slower recovery with a median of 21.5 minutes. Median and quartile data are presented with censored observations indicated.*

FDA Label Image

Figure 2 (Bridion 04)

A cumulative recovery rate chart comparing sugammadex 2 mg/kg versus neostigmine 0.05 mg/kg over 120 minutes. The x-axis represents time to recovery in minutes, and the y-axis shows cumulative recovery rates, with markers indicating medians, quartiles, and censored observations. Sugammadex demonstrates faster recovery than neostigmine according to the median recovery times displayed in the inset box.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.